Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 96 Carcinoma, Non-Small-Cell Lung 85 Prostatic Neoplasms 75 Multiple Myeloma 74 Neoplasms 50 Leukemia, Myeloid, Acute 44 Lymphoma 43 Melanoma 42 Neoplasm Metastasis 39 Ovarian Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 35 Lymphoma, Non-Hodgkin 34 Lung Neoplasms 34 Leukemia, Lymphocytic, Chronic, B-Cell 32 Hematologic Neoplasms 29 Colorectal Neoplasms 29 Triple Negative Breast Neoplasms 27 Hodgkin Disease 24 Pancreatic Neoplasms 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Myelodysplastic Syndromes 21 Fallopian Tube Neoplasms 21 Carcinoma, Renal Cell 21 Sarcoma 20 Lymphoma, Follicular 20 Urinary Bladder Neoplasms 18 Recurrence 18 Lymphoma, Mantle-Cell 18 Head and Neck Neoplasms 18 Brain Neoplasms 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Solid Tumor, Adult × 90 days × Clear all

NCT05582850 2026-05-12

EPRAD

Domain Therapeutics SA

Phase 1 Terminated

29 enrolled 12 charts

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡